Ghent University Academic Bibliography

Journal Article
A1
open access

Glofitamab in relapsed/refractory mantle cell lymphoma : results from a phase I/II study

Tycel Jovelle Phillips, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Marek Trneny, Nancy L. Bartlett, Jan Zaucha, Tomasz Wrobel, Fritz Offner (UGent) , et al.

(2025) JOURNAL OF CLINICAL ONCOLOGY. 43(3). p.318-328

Add to list

Journal Article
A1
open access

CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy

Bert Luyckx (UGent) , Maaike Van Trimpont (UGent) , Fien Declerck, Eleni Staessens (UGent) , Annick Verhee (UGent) , Sara T'Sas (UGent) , Sven Eyckerman (UGent) , Fritz Offner (UGent) , Pieter Van Vlierberghe (UGent) , Steven Goossens, et al.

(2025) PHARMACOLOGICAL RESEARCH. 215.

Add to list

Real-world evaluation of treatments and outcomes of follicular lymphoma in Belgium

Willem Daneels (UGent) , Gustaaf Claeys, Yaro Preem and Fritz Offner (UGent)

(2025) 40th General Annual Meeting of the Belgian Hematology Society 2025, Abstracts.

Add to list

Predicting cytogenetic risk in newly-diagnosed multiple myeloma patients using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI and spinal diffusion-weighted imaging

Thomas Van Den Berghe (UGent) , Bert Verberckmoes, Nicolas Kint (UGent) , Steven Wallaert (UGent) , Chloé Algoet (UGent) , Julie Dutoit (UGent) , Amélie Dendooven (UGent) , Fritz Offner (UGent) and Koenraad Verstraete (UGent)

(2024) European Congress of Radiology 2024 (ECR 2024), Abstracts.

Add to list

Journal Article
A1
open access

High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma

Willem Daneels (UGent) , Alexander Van Parys (UGent) , Leander Huyghe (UGent) , Elke Rogge (UGent) , Steffi De Rouck (UGent) , Ruben Christiaen, Lennart Zabeau (UGent) , Sylvie Taveirne (UGent) , Jo Van Dorpe (UGent) , Niko Kley, et al.

(2024) EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 13(1).

Add to list

Predicting cytogenetic risk in newly-diagnosed multiple myeloma patients using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI and spinal diffusion-weighted imaging

Thomas Van Den Berghe (UGent) , Bert Verberckmoes, Nicolas Kint (UGent) , Steven Wallaert (UGent) , Chloé Algoet (UGent) , Julie Dutoit (UGent) , Amélie Dendooven (UGent) , Fritz Offner (UGent) and Koenraad Verstraete (UGent)

(2024) European Congress of Radiology 2024 (ECR 2024), Abstracts.

Add to list

Journal Article
A1
open access

Characterizing the cell-free transcriptome in a humanized diffuse large B-cell lymphoma patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Philippe Decruyenaere (UGent) , Willem Daneels (UGent) , Annelien Morlion (UGent) , Kimberly Verniers (UGent) , Jasper Anckaert (UGent) , Jan Tavernier (UGent) , Fritz Offner (UGent) and Jo Vandesompele (UGent)

(2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(18).

Add to list

Research Data

Characterizing the cell-free transcriptome in a humanized DLBCL patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Philippe Decruyenaere (UGent) , Jo Vandesompele (UGent) , Willem Daneels (UGent) and Fritz Offner (UGent)

(2024)

Add to list

Journal Article
A1
open access

Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen-induced exhaustion

Stijn De Munter (UGent) , Juliane L. Buhl, Laurenz De Cock (UGent) , Alexander Van Parys (UGent) , Willem Daneels (UGent) , Eva Pascal (UGent) , Lucas Deseins (UGent) , Joline Ingels (UGent) , Glenn Goetgeluk (UGent) , Hanne Jansen, et al.

(2024) CANCER IMMUNOLOGY RESEARCH. 12(9). p.1236-1251

Add to list

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma : long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Sonja Zweegman, Helene Caillon, Denis Caillot, Herve Avet-Loiseau, et al.

(2024) LANCET ONCOLOGY. 25(8). p.1003-1014

Academic Bibliography

Glofitamab in relapsed/refractory mantle cell lymphoma : results from a phase I/II study

CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy

Real-world evaluation of treatments and outcomes of follicular lymphoma in Belgium

Predicting cytogenetic risk in newly-diagnosed multiple myeloma patients using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI and spinal diffusion-weighted imaging

High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma

Predicting cytogenetic risk in newly-diagnosed multiple myeloma patients using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI and spinal diffusion-weighted imaging

Characterizing the cell-free transcriptome in a humanized diffuse large B-cell lymphoma patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Characterizing the cell-free transcriptome in a humanized DLBCL patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting

Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen-induced exhaustion

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma : long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

Contents

Support

Contact